| GABA-transaminase deficiency | ABAT | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✗ | 
         
      | Ichthyosis | ABCA12 | 16 | 0.00670017 | 0.0133106 | 0.000177171 | ✓ | 
         
      | Retinal dystrophy | ABCA4 | 53 | 0.0221943 | 0.0434034 | 0.00188386 | ✓ | 
         
      | Pseudoxanthoma elasticum | ABCC6 | 11 | 0.00460637 | 0.00917029 | 0.0000841 | ✓ | 
         
      | Hyperinsulinism | ABCC8 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Sitosterolemia 1 | ABCG8 | 10 | 0.0041876 | 0.00834014 | 0.0000696 | ✓ | 
         
      | Isobutyryl-CoA dehydrogenase deficiency | ACAD8 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Acyl-CoA dehydrogenase | ACADM | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Short-chain acyl-CoA-dehydrogenase deficiency | ACADS | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Inborn error of metabolism | ACADSB | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Very long chain acyl-CoA dehydrogenase deficiency | ACADVL | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Optic atrophy 9 | ACO2 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Adenosine deaminase deficiency | ADA | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Sneddon syndrome | ADA2 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Reduced expression | ADAMTS13 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Weill-Marchesani syndrome | ADAMTS17 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Microcornea, myopic chorioretinal atrophy and telecanthus | ADAMTS18 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Deafness, non-syndromic, autosomal recessive | ADGRV1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Sengers syndrome | AGK | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
         
      | Glycogen storage disease 3 | AGL | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Congenital myasthenic syndrome with distal muscle weakness & atrophy | AGRN | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Hyperoxaluria | AGXT | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Joubert syndrome | AHI1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Leber congenital amaurosis IV | AIPL1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Autoimmune polyendocrinopathy syndrome | AIRE | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Bile acid synthesis defect | AKR1D1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Sjogren-Larsson syndrome | ALDH3A2 | 15 | 0.00628141 | 0.0124839 | 0.000155848 | ✓ | 
         
      | Epilepsy | ALDH7A1 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Fructose intolerance | ALDOB | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Congenital disorder of glycosylation | ALG1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Congenital disorder of glycosylation 1i | ALG2 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Congenital disorder of glycosylation | ALG3 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Congenital disorder of glycosylation 1h | ALG8 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Alstrom syndrome | ALMS1 | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
         
      | Odontohypophosphatasia | ALPL | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Cerebellar ataxia 3 | ANO10 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Muscular dystrophy, limb girdle 2L | ANO5 | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Hyaline fibromatosis syndrome | ANTXR2 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Spastic paraplegia 52 | AP4S1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Ataxia | APTX | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Metachromatic leukodystrophy | ARSA | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Mucopolysaccharidosis type VI (Maroteaux-Lamy) | ARSB | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Spinal muscular atrophy with progressive myoclonic epilepsy | ASAH1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Argininosuccinic aciduria | ASL | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Microcephaly 5 | ASPM | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Ataxia-telangiectasia | ATM | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Kufor-Rakeb syndrome | ATP13A2 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Autism spectrum disorder | ATP2A1 | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Wilson disease | ATP7B | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Neurodevelopmental disorder with poor growth and behavioral abnormalities | ATP9A | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Pulmonary fibrosis / aplastic anaemia | ATR | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Nephrotic syndrome | AVIL | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
         
      | Muscular dystrophy-dystroglycanopathy | B3GALNT2 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Spondyloepimetaphyseal dysplasia with joint laxity | B3GALT6 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Multiple joint dislocations | B3GAT3 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Peters-Plus syndrome | B3GLCT | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Spastic paraplegia | B4GALNT1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Phenotype modifier | BBS5 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Bardet-Biedl syndrome, modifier of | BBS7 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Retinitis pigmentosa | BBS9 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Butyrylcholinesterase deficiency | BCHE | 29 | 0.0121441 | 0.0239932 | 0.000575671 | ✓ | 
         
      | GRACILE syndrome | BCS1L | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Breast cancer | BLM | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Biotinidase deficiency | BTD | 17 | 0.00711893 | 0.0141365 | 0.000199841 | ✓ | 
         
      | Autism spectrum disorder | C2CD3 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Complement C5 deficiency | C5 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Inflammatory bowel disease, very early onset | C6 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Alzheimer disease in Han Chinese, association with | C7 | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
         
      | Complement C8 alpha-gamma deficiency | C8A | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
         
      | Primary immunodeficiency disease | C8B | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Carbonic anhydrase VA deficiency | CA5A | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Retinal dystrophy | CABP4 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Muscular dystrophy, limb girdle 2A | CAPN3 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Homocystinuria | CBS | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Primary ciliary dyskinesia | CCDC103 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Primary ciliary dyskinesia | CCDC39 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Primary ciliary dyskinesia | CCDC40 | 8 | 0.00335008 | 0.00667772 | 0.0000446 | ✓ | 
         
      | Pseudorheumatoid dysplasia, progressive | CCN6 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Ciliary dyskinesia | CCNO | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
         
      | Platelet glycoprotein IV deficiency | CD36 | 41 | 0.0171692 | 0.0337488 | 0.00113898 | ✓ | 
         
      | Usher syndrome | CDH23 | 11 | 0.00460637 | 0.00917029 | 0.0000841 | ✓ | 
         
      | Hypotrichosis | CDH3 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Autism spectrum disorder | CDK5RAP2 | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
         
      | Intellectual disability | CENPJ | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Seckel syndrome | CEP152 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Leber congenital amaurosis 10 | CEP290 | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Ichthyosis | CERS3 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Retinitis pigmentosa | CFAP410 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Dextrocardia and situs disturbances | CFAP53 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Cystic fibrosis | CFTR | 8 | 0.00335008 | 0.00667772 | 0.0000446 | ✓ | 
         
      | Congenital myasthenic syndrome | CHRNE | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Multiple pterygium syndrome | CHRNG | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Bartter syndrome | CLCNKB | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Congenital short-bowel syndrome | CLMP | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Retinal dystrophy, early-onset | CLN3 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Achromatopsia 2 | CNGA3 | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
         
      | Achromatopsia 3 | CNGB3 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Hypogonadotropic hypogonadism | CNTN2 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Hypomyelinating neuropathy | CNTNAP1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Schizophrenia | COG7 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Epithelial recurrent erosion dystrophy | COL17A1 | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
         
      | Knobloch syndrome | COL18A1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Steel syndrome | COL27A1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Bethlem myopathy 1 | COL6A2 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | EBD | COL7A1 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Primary coenzyme Q10 deficiency, neonatal onset | COQ9 | 8 | 0.00335008 | 0.00667772 | 0.0000446 | ✓ | 
         
      | Haemophagocytic lymphohistiocytosis | CORO1A | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Hypertrophic cardiomyopathy, early onset | COX15 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Dysarthria, ataxia and sensory neuropathy | COX20 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Joubert syndrome | CPLANE1 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Leber congenital amaurosis 8 | CRB1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Congenital nephrosis, Finnish type-like, with cerebral ventriculomegaly & raised alpha-fetoprotein | CRB2 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Short stature, microcephaly & dysmorphic facies | CRIPT | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Cystinosis | CTNS | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Pycnodysostosis | CTSK | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Albuminuria, association with | CUBN | 52 | 0.0217755 | 0.0426027 | 0.00181499 | ✓ | 
         
      | 3-M syndrome 1 | CUL7 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Steroid-11 beta-hydroxylase deficiency | CYP11B1 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Glaucoma 3A | CYP1B1 | 27 | 0.0113065 | 0.0223574 | 0.000499853 | ✓ | 
         
      | Hyperandrogenism | CYP21A2 | 135 | 0.0565327 | 0.106673 | 0.0113792 | ✓ | 
         
      | Cerebrotendinous xanthomatosis | CYP27A1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Retinitis pigmentosa | CYP4V2 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Leukoencephalopathy with brainstem & spinal cord involvement | DARS2 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Diarrhea | DGAT1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Portal hypertension | DGUOK | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Miller syndrome | DHODH | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Congenital scoliosis | DLL3 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Neural tube defects | DNAAF1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Ciliary dyskinesia | DNAH11 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Primary ciliary dyskinesia | DNAH5 | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
         
      | Situs inversus and male infertility | DNAH9 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Systemic lupus erythematosus 16 | DNASE1L3 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Adams-Oliver syndrome 2 | DOCK6 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Immunodeficiency, primary | DOCK8 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Fetal akinesia deformation sequence 3 | DOK7 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Microcephaly | DONSON | 23 | 0.00963149 | 0.0190775 | 0.000363949 | ✓ | 
         
      | Congenital disorder of glycosylation 1 | DPAGT1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Dihydropyrimidine dehydrogenase deficiency | DPYD | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Dihydropyrimidinase deficiency | DPYS | 8 | 0.00335008 | 0.00667772 | 0.0000446 | ✓ | 
         
      | Cardiomyopathy, arrhythmogenic right ventricular | DSP | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Hypothyroidism | DUOX2 | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Asphyxiating thoracic dystrophy | DYNC2H1 | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Short-rib thoracic dysplasia 8 with or without polydactyly | DYNC2I1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Arthrogryposis | ECEL1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Short-chain enoyl-CoA hydratase deficiency | ECHS1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Ectodermal dysplasia 11A | EDARADD | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Autism spectrum disorder | ELP1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Vici syndrome | EPG5 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Basal cell carcinoma, reduced risk, association with | ERCC2 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Hearing loss | ESPN | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Ellis-van Creveld syndrome | EVC2 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Pontocerebellar hypoplasia 1 | EXOSC3 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Epidermolysis bullosa, junctional | EXPH5 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Retinitis pigmentosa | EYS | 15 | 0.00628141 | 0.0124839 | 0.000155848 | ✓ | 
         
      | Factor XI deficiency | F11 | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Thrombophilia 1 due to thrombin defect | F2 | 22 | 0.00921273 | 0.0182557 | 0.000333271 | ✓ | 
         
      | Factor VII deficiency | F7 | 18 | 0.00753769 | 0.0149617 | 0.000223854 | ✓ | 
         
      | Spastic paraplegia 35 | FA2H | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Tyrosinemia | FAH | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Retinitis pigmentosa | FAM161A | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Fanconi anemia | FANCC | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Fructose-1,6-bisphosphatase deficiency | FBP1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Parkinsonism, juvenile | FBXO7 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Multiple leiomyomatosis | FH | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Amyotrophic lateral sclerosis, sporadic | FIG4 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Posterior column ataxia & retinitis pigmentosa | FLVCR1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Complex I deficiency | FOXRED1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Congenital anomalies of the kidney and urinary tract | FRAS1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Intellectual disability, developmental delay & seizures | FRRS1L | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Formiminoglutamic acidura | FTCD | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Glycogen storage disease Ia | G6PC1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Glycogen storage disease II | GAA | 10 | 0.0041876 | 0.00834014 | 0.0000696 | ✓ | 
         
      | Krabbe disease | GALC | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
         
      | Galactokinase deficiency, presenile cataract | GALK1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Mucopolysaccharidosis IVA | GALNS | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Tumoral calcinosis | GALNT3 | 16 | 0.00670017 | 0.0133106 | 0.000177171 | ✓ | 
         
      | Cerebral creatine deficiency syndrome 2 | GAMT | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Gaucher disease | GBA | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Spastic paraplegia | GBA2 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Glycogen storage disease 4 | GBE1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Glutaric acidaemia 1 | GCDH | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
         
      | Charcot-Marie-Tooth disease | GDAP1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Congenital myasthenic syndrome | GFPT1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Hypogonadotropic hypogonadism | GHR | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Hearing loss, non-syndromic | GIPC3 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Keratoderma | GJB2 | 30 | 0.0125628 | 0.02481 | 0.000615535 | ✓ | 
         
      | GM1-gangliosidosis | GLB1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Glycine encephalopathy | GLDC | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | GNE myopathy | GNE | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Mucolipidosis III alpha/beta | GNPTAB | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Hypogonadotropic hypogonadism | GNRHR | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
         
      | Absence of collagen-induced platelet activation | GP6 | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Hyperekplexia | GPHN | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Autism spectrum disorder | GPR179 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Hyperoxaluria II | GRHPR | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Congenital stationary night blindness | GRM6 | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Glycogen storage disease 0 | GYS2 | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
         
      | Mitochondrial trifunctional protein deficiency | HADHB | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Haemoglobin variant | HBA1 | 34 | 0.0142379 | 0.0280703 | 0.000787941 | ✓ | 
         
      | Haemoglobin variant | HBA2 | 22 | 0.00921273 | 0.0182557 | 0.000333271 | ✓ | 
         
      | Haemoglobin variant | HBB | 121 | 0.05067 | 0.0962051 | 0.00925543 | ✓ | 
         
      | Haemoglobin variant | HBD | 31 | 0.0129816 | 0.0256261 | 0.000656697 | ✓ | 
         
      | [Hex A pseudodeficiency] | HEXA | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Alkaptonuria | HGD | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Mucopolysaccharidosis type IIIC (Sanfilippo C) | HGSNAT | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Hermansky-Pudlak syndrome 3 | HPS3 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Apparent mineralocorticoid excess | HSD11B2 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Pseudohermaphroditism, male | HSD17B3 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | D-bifunctional protein deficiency | HSD17B4 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Scoliosis, idiopathic, association with | HSPG2 | 14 | 0.00586265 | 0.0116566 | 0.000135875 | ✓ | 
         
      | Hurler syndrome | IDUA | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Leber congenital amaurosis | IFT140 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Mycobacterial infection | IL12RB1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | IL-17RA deficiency with bacterial and fungal infections | IL17RA | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Joubert syndrome 1 | INPP5E | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Leber congenital amaurosis | IQCB1 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Leukocyte adhesion deficiency | ITGB2 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Bleeding disorder | ITGB3 | 15 | 0.00628141 | 0.0124839 | 0.000155848 | ✓ | 
         
      | Hirschsprung disease | ITGB4 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Isovaleric acidemia | IVD | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Hypothyroidism | IYD | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Immunodeficiency, severe combined | JAK3 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Bartter syndrome | KCNJ1 | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Retinal cone dystrophy 3B | KCNV2 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Joubert syndrome | KIAA0586 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Cerebellar ataxia | KIF1C | 10 | 0.0041876 | 0.00834014 | 0.0000696 | ✓ | 
         
      | Macrocephaly, multiple epiphyseal dysplasia & facial features | KIF7 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Retinitis pigmentosa 42 | KLHL7 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Schizophrenia | LAMA1 | 9 | 0.00376884 | 0.00750928 | 0.0000564 | ✓ | 
         
      | Epidermolysis bullosa, junctional | LAMA3 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Pierson syndrome/ nephrotic syndrome type 5 | LAMB2 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Epidermolysis bullosa, Herlitz | LAMC2 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | LDL cholesterol level QTL2 | LDLR | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Hypopituitarism and sensorineural hearing loss | LHX3 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome | LIFR | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Marfan syndrome, early-onset | LIG4 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Intellectual developmental disorder | LINS1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Factor V and factor VIII deficiency, combined | LMAN1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Triphalangeal thumbs and preaxial polydactyly | LMBR1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Mandibuloacral dysplasia | LMNA | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Deafness | LOXHD1 | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
         
      | Myopia 28 | LOXL3 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Hyperlipidaemia | LPL | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Infantile mitochondrial disease, lethal | LRPPRC | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Osteosclerotic metaphyseal dysplasia | LRRK1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Chediak-Higashi syndrome | LYST | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Immunodeficiency, combined | MALT1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Nephronophthisis, late onset | MAPKBP1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Ciliary dyskinesia | MCIDAS | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Neutrophilic dermatosis | MEFV | 73 | 0.0305695 | 0.05927 | 0.00351294 | ✓ | 
         
      | Parkinson disease, early onset | MKS1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Methylmalonic aciduria and homocystinuria | MMACHC | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Homocystinuria, cblD type | MMADHC | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Methylmalonic aciduria | MMUT | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Thiopurine-induced toxicity | MOCOS | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Thrombocytosis, association with | MPL | 9 | 0.00376884 | 0.00750928 | 0.0000564 | ✓ | 
         
      | Trichothiodystrophy, nonphotosensitive | MPLKIP | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Mitochondrial DNA depletion syndrome, hepatocerebral | MPV17 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Breast cancer | MRE11 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Cleft lip with or without cleft palate | MTRR | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Hyper-IgD syndrome | MVK | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Deafness, non-syndromic, autosomal recessive | MYO15A | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Diarrhea 2 | MYO5B | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
         
      | Bone, connective tissue, liver, immune system & retinal defects | NBAS | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Breast cancer, male | NBN | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Chronic granulomatous disease | NCF1 | 8 | 0.00335008 | 0.00667772 | 0.0000446 | ✓ | 
         
      | Chronic granulomatous disease | NCF2 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Leigh syndrome/Mitochondrial Complex I deficiency | NDUFAF5 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Neurodevelopmental disorder | NDUFS1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Amyotrophic lateral sclerosis | NEK1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Renal disease with hepatic and cardiac anomalies | NEK8 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Spastic ataxia 8 | NKX6-2 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Nephronophthisis 1 | NPHP1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Nephronophthisis 4 | NPHP4 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Nephrotic syndrome | NPHS1 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Retinitis pigmentosa 37 | NR2E3 | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
         
      | Complex I deficiency | NUBPL | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Cardiomyopathy, dilated | OBSL1 | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
         
      | Pseudo-TORCH syndrome 1 | OCLN | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Optic atrophy plus syndrome | OPA1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Lymphoproliferative disorder | ORC4 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Meier-Gorlin syndrome | ORC6 | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
         
      | Hearing loss | OTOA | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Deafness, non-syndromic | OTOF | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Hearing loss, sensorineural | OTOG | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Hearing impairment | OTOGL | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Hyperphenylalaninemia | PAH | 40 | 0.0167504 | 0.0329397 | 0.00108502 | ✓ | 
         
      | Neurodegeneration with brain iron accumulation 1 | PANK2 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Hyperinsulinism | PC | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Retinitis pigmentosa 54 | PCARE | 8 | 0.00335008 | 0.00667772 | 0.0000446 | ✓ | 
         
      | Propionicacidemia | PCCB | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Usher syndrome 1 | PCDH15 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Retinitis pigmentosa, pericentral | PDE6B | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Tourette syndrome | PDP1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Prolidase deficiency | PEPD | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Zellweger syndrome | PEX1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Peroxisome biogenesis disorder 3B | PEX12 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Peroxisome biogenesis disorder 8B | PEX16 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Refsum disease, infantile | PEX26 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Peroxisome biogenesis disorder 4B | PEX6 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Congenital disorder of glycosylation | PGM1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Fetal alcohol syndrome, predisposition to | PGM3 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Primary microcephaly | PHC1 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Neu-Laxova syndrome 1 | PHGDH | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | PIGO deficiency | PIGO | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
         
      | Deafness | PJVK | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Polycystic kidney disease 4 | PKHD1 | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Pyruvate kinase deficiency | PKLR | 18 | 0.00753769 | 0.0149617 | 0.000223854 | ✓ | 
         
      | Infantile neuroaxonal dystrophy | PLA2G6 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Myopathy | PLEKHG5 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Ehlers-Danlos syndrome | PLOD1 | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Congenital disorder of glycosylation 1a | PMM2 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Nucleoside phosphorylase deficiency | PNP | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Pyridoxamine 5'-phosphate oxidase deficiency | PNPO | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Mitochondrial recessive ataxia syndrome | POLG | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Altered function | POR | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Camptodactyly-arthropathy-coxa vara-pericarditis syndrome | PRG4 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Neural tube defects | PRICKLE1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Thrombophilia 3 due to protein C deficiency | PROC | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Hypotonia, microcephaly and global developmental delay | PRUNE1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Combined SAP deficiency | PSAP | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Developmental disorder | PSAT1 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Congenital sensorineural hearing loss, autosomal recessive | PTPRQ | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Tetrahydrobiopterin deficiency | PTS | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Glycogen storage disease 6 | PYGL | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | McArdle disease | PYGM | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Microcephaly | QARS1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Dihydropteridine reductase deficiency | QDPR | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Microphthalmia & cataract | RAB3GAP2 | 10 | 0.0041876 | 0.00834014 | 0.0000696 | ✓ | 
         
      | Omenn syndrome | RAG1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Congenital myasthenic syndrome | RAPSN | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Pulmonary arterial hypertension | RARS2 | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
         
      | Microphthalmia | RAX | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Baller-Gerold syndrome | RECQL4 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | MHC class II deficiency | RFXANK | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Aicardi-Goutieres syndrome 4 | RNASEH2A | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Aicardi-Goutières syndrome | RNASEH2B | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Aicardi-Goutieres syndrome 3 | RNASEH2C | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Gaze palsy | ROBO3 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Kohlschütter-Tönz syndrome | ROGDI | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Cone-rod dystrophy 13 | RPGRIP1 | 11 | 0.00460637 | 0.00917029 | 0.0000841 | ✓ | 
         
      | Primary microcephaly & primordial dwarfism | RTTN | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Congenital myopathy 1B | RYR1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Spastic ataxia, Charlevoix-Saguenay | SACS | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Retinitis pigmentosa, autosomal recessive | SAG | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Shwachman-Diamond syndrome | SBDS | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Charcot-Marie-Tooth disease | SBF1 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Paramyotonia congenita | SCN4A | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Childhood absence epilepsy | SCN9A | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Anaemia, dyserythropoietic congenital, type II | SEC23B | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Cerebellar atrophy | SEPSECS | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Reduced alpha-1-antitrypsin concentration | SERPINA1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Osteogenesis imperfecta | SERPINF1 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Muscular dystrophy | SGCD | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Muscular dystrophy, limb girdle | SGCG | 32 | 0.0134003 | 0.0264415 | 0.000699155 | ✓ | 
         
      | Mucopolysaccharidosis type IIIA (Sanfilippo A) | SGSH | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Sucrase isomaltase deficiency | SI | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
         
      | Macular degeneration, age related, reduced risk | SKIV2L | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Gitelman syndrome | SLC12A3 | 8 | 0.00335008 | 0.00667772 | 0.0000446 | ✓ | 
         
      | Wernicke's-like encephalopathy | SLC19A3 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Carnitine deficiency | SLC22A5 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Intrahepatic cholestasis, neonatal | SLC25A13 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Thiamine metabolism dysfunction syndrome 4 | SLC25A19 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Carnitine-acylcarnitine translocase deficiency | SLC25A20 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Deafness | SLC26A4 | 19 | 0.00795645 | 0.0157863 | 0.000249207 | ✓ | 
         
      | Glucose transporter type 1 deficiency syndrome | SLC2A1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | ?Fanconi renotubular syndrome 2 | SLC34A1 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Schneckenbecken dysplasia | SLC35D1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Glycogen storage disease 1b | SLC37A4 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Foveal hypoplasia, optic nerve decussation defects and anterior segment dysgenesis | SLC38A8 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | ?Hyperostosis cranalis interna | SLC39A14 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Cystinuria | SLC3A1 | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
         
      | Neuronopathy | SLC5A7 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Hartnup disorder | SLC6A19 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Niemann-Pick disease | SMPD1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Neuronopathy, distal hereditary motor, autosomal recessive 8 | SORD | 12 | 0.00502513 | 0.00999975 | 0.0001 | ✓ | 
         
      | Leber congenital amaurosis 3 | SPATA7 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Charcot-Marie-Tooth disease | SPG11 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Spastic paraplegia | SPG7 | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Spherocytosis | SPTA1 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Deafness, non-syndromic | STRC | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Neurodevelopmental disorder with ataxia | SVBP | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Ichthyosiform erythroderma, congenital, nonbullous | TGM1 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Intellectual disability | THOC6 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Deafness | TMC1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Cerebro-facio-thoracic dysplasia | TMCO1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Oral-facial-digital syndrome | TMEM107 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Joubert syndrome 16 | TMEM138 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Meckel syndrome | TMEM231 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Joubert syndrome related disorder | TMEM237 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Nephronophthisis 11 | TMEM67 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Hearing loss | TMPRSS3 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
         
      | Hemolytic anemia due to triosephosphate isomerase deficiency | TPI1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | Thyroid dyshormonogenesis 2A | TPO | 15 | 0.00628141 | 0.0124839 | 0.000155848 | ✓ | 
         
      | Hearing loss | TPRN | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
         
      | Hypogonadotropic hypogonadism, normosmic | TRAPPC9 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Developmental disorder | TRIOBP | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
         
      | Spinal muscular atrophy & congenital bone fractures | TRIP4 | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
         
      | Neurodevelopmental disorder | TRMT10A | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Night blindness | TRPM1 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Intellectual disability & epilepsy | TSEN54 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Bardet-Biedl syndrome | TTC21B | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
         
      | Fatigue, failure to thrive & diarrhoea | TTC37 | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
         
      | Immunodeficiency, combined, with intestinal atresias | TTC7A | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Muscular dystrophy | TTN | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Diaphragmatic hernia | TUBGCP6 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
         
      | Albinism, oculocutaneous | TYR | 14 | 0.00586265 | 0.0116566 | 0.000135875 | ✓ | 
         
      | Johanson-Blizzard syndrome | UBR1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | ?Hip dysplasia | UFSP2 | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
         
      | Beta-ureidopropionase deficiency | UPB1 | 10 | 0.0041876 | 0.00834014 | 0.0000696 | ✓ | 
         
      | Retinitis Pigmentosa | USH2A | 13 | 0.00544389 | 0.0108285 | 0.000117256 | ✓ | 
         
      | Mitochondrial encephalopathy | VARS2 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Rickets | VDR | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Cohen syndrome | VPS13B | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
         
      | Arthrogryposis, renal dysfunction and cholestasis | VPS33B | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Parkinson disease, early onset | VPS53 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | von Willebrand disease | VWF | 9 | 0.00376884 | 0.00750928 | 0.0000564 | ✓ | 
         
      | Short rib-polydactyly syndrome | WDR35 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Microcephaly, primary | WDR62 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Usher syndrome | WHRN | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Werner syndrome | WRN | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
         
      | NPHP-like kidney disease | XPNPEP3 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Desbuquois dysplasia 2 | XYLT1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
         
      | Spastic paraplegia with thin corpus callosum | ZFYVE26 | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ |